In 16 consecutive patients with clinically suspected and biochemically
proven X-linked adrenoleukodystrophy (X-ALD), total delay (interval b
etween onset of symptoms and diagnosis) and specialist delay (interval
between referral to a specialist and diagnosis) were determined. All
patients previously were unaware of the existence of X-ALD in their fa
milies. From the time of onset of symptoms attributable to this diseas
e until diagnosis, mean total delay was 9.9 (range 1-33) years and mea
n specialist delay was 8.4 (range 0-33) years. Three patients who pres
ented with adrenocortical insufficiency had mean total and specialist
delays of 17.3 (range 9-33) years. Five patients with an initial diagn
osis of multiple sclerosis had mean total and specialist delays of 12.
8 (range 5-25) and 11.2 (range 1-23) years, respectively. In 12 patien
ts with adrenomyeloneuropathy-the second most frequent phenotype of X-
ALD - mean total delay was 11.0 (range 2-33) years and mean specialist
delay 9.1 (range 0-33) years. Since 1981 X-ALD can be reliably diagno
sed on the basis of elevated levels of very long chain fatty acids in
plasma and/or cultured fibroblasts. The delays therefore must have bee
n due to the unfamiliarity with the clinical manifestations and diagno
stic possibilities of this disease. Once X-ALD is diagnosed, dietary t
reatment and/or bone marrow transplantation may be considered. Genetic
counseling should be performed, and screening of other family members
is essential for the early identification of affected relatives.